Literature DB >> 23869725

Eczema and ceramides: an update.

Jakob Mutanu Jungersted1, Tove Agner.   

Abstract

Although normal epidermal barrier function depends on numerous factors, including corneocytes, lipids, enzymes, pH, and calcium gradient, the key players are lipids and proteins in the stratum corneum. Atopic dermatitis is characterized by barrier abnormalities, such as the presence of filaggrin mutations in almost 50% of patients with moderate/severe atopic dermatitis, and lipid disturbances, mainly expressed as insufficient ceramides. In this review, with an emphasis on human studies, we consider the latest research on ceramides, on ceramides in different types of eczema and following various types of treatment. We also consider the genetic influence on stratum corneum lipids. The review is an update on research indexed in PubMed following the discovery of the filaggrin mutations in atopic dermatitis in 2006, but when newer publications cannot stand alone, we include publications from before 2006.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ceramides; eczema; occlusion and genetics; treatment

Mesh:

Substances:

Year:  2013        PMID: 23869725     DOI: 10.1111/cod.12073

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

Review 1.  Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Authors:  Eric Schauberger; Miriam Peinhaupt; Tareian Cazares; Andrew W Lindsley
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

2.  Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial.

Authors:  Alessia Marseglia; Amelia Licari; Fabio Agostinis; Antonio Barcella; Domenico Bonamonte; Mario Puviani; Massimo Milani; GianLuigi Marseglia
Journal:  Pediatr Allergy Immunol       Date:  2014-05       Impact factor: 6.377

3.  The Anti-Inflammatory Effect of Humulus lupulus Extract In Vivo Depends on the Galenic System of the Topical Formulation.

Authors:  Zita Hurth; Marie-Luise Faber; Fabian Gendrisch; Martin Holzer; Birgit Haarhaus; Anja Cawelius; Kay Schwabe; Christoph Mathis Schempp; Ute Wölfle
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.